Minimal Residual Disease Testing Market: Driving Precision and Personalization in Cancer Care The global market for minimal residual disease (MRD) testing is experiencing significant growth, driven by the increasing prevalence of cancer, especially blood cancers, high recurrence rates in various cancer types, and increased investments in MRD research. The demand for MRD testing is expected to expand further as personalized treatments and targeted oncology therapies gain traction,...
0 Geteilt
104 Ansichten
0 Bewertungen